DRUG-DRUG INTERACTIONS IIKE A REASON OF ADVERSE DRUG REACTIONS
- Issue: Vol 21, No 3 (2013)
- Pages: 70-76
- Section: Articles
- URL: https://journal-vniispk.ru/pavlovj/article/view/4767
- DOI: https://doi.org/10.17816/PAVLOVJ2013370-76
- ID: 4767
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Разработка методов изучения и профилактики осложнений фармакотерапии: учебное пособие / В.К. Лепахин [и др.]. – М.: РУДН, 2008. – 225 с.
- Сюбаев Р.Д. Принципы доклинической оценки риска токсикологического взаимодействия лекарственных средств и критерии безопасности комбинированной фармакотерапии: автореф. дис. … д-ра мед. наук / Р.Д. Сюбаев. – М., 2012. – 24 с.
- Осложнения фармакотерапии. Лекарственное взаимодействие / С.Б. Фитилев [и др.]. – М.: ООО "Петроруш"2011. – 56 с.
- Angelin B. Quinidine reduces biliary clearance of digoxin in man / B. Angelin, A. Arvidsson, R. Dahlqvist // EurJ Clin Invest. – 1987. – №17. – Р. 262-265.
- Baldwin S.J. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9 / S.J. Baldwin, J.C. Bloomer, G.J. Smith // Xenobiotica. – 1995. – №25. – Р. 261-270.
- Bergendal L. Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden./ L. Bergendal, A. Friberg, A.M. Schaffrath // Pharm World Sci. – 1995. – №17. – Р. 152-157.
- Bjorkman I.K. Drug-drug interactions in the elderly / I.K. Bjorkman, J. Fastbom, I.K. Schmidt // Ann Pharmacother. – 2002. – № 36(11). – Р. 1675-1681.
- Burns J.J. Enzyme stimulation and inhibition in the metabolism of drugs / J.J. Burns, A.H. Conney // Proceedings of the Royal Society of Medicine. – 1965. – №58. – Р. 955-960.
- Christensen L.K. Sulphaphenazoleinduced hypoglycaemic attacks in tolbutamide-treated diabetics / L.K. Christensen, J.M. Hansen, M. Kristens // Lancet. – 1963. – №2. – Р. 298-301.
- Cruciol-Souza J.M. A pharmaco epidemiologic study of drug interactions in a Brazilian teaching hospital / J.M. Cruciol-Souza, J.C. Thomson // Clinics. – 2006. – №61(6). – Р. 515-520.
- Delafuente J.C. Understanding and preventing drug interactions in elderly patients / J.C. Delafuente // Crit Rev Oncol Hematol. – 2003. – №48(2). – Р.133-143.
- Dunphy T.W. The pharmacist's role in the prevention of adverse drug interactions / T.W. Dunphy // Am J Hosp Pharm. – 1969. – №26(7). – Р. 366-377.
- Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin / G. Ejvinsson // BMJ. – 1978. – №1. – Р. 279-280.
- Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review / A.X. Garg [et al.] // JAMA. – 2005. – №293(10). – Р. 1223-1238.
- Geppert U. Drug interactions in clinical practice. A pilot project for quality assurance in prescribing / U. Geppert, W. Beindl, T. Hawranek // Hautarzt. – 2003. – №54(1). – Р. 53-57.
- Hedman A. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine / A. Hedman, B. Angelin, A. Arvidsson // Clin Pharmacol Ther. – 1990. – №47. – Р. 20-26.
- Hohl C.M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department / C.M. Hohl, J. Dankoff, A. Colacone // Ann Emerg Med. – 2001. – №38(6). – Р. 666-671.
- Juurlink D.N. Drug-drug interactions among elderly patients hospitalized for drug toxicity / D.N. Juurlink, M Mamdani, A Kopp // JAMA. – 2003. – №289 (13). – Р. 1652-1658.
- McDonnell P.J. Hospital admissions resulting from preventable adverse drug reactions / P.J. McDonnell, M.R. Jacobs // The Annals of Pharmacotherapy. – 2002. – №36. – Р. 1331-1336.
- Salassa R.M. The effect of para-aminobenzoic acid on the metabolism and excretion of salicylate / R.M. Salassa, J.L. Bollman, T.J. Dry // J Lab Clin Med. – 1948. – 33(11). – Р. 1393-1401.
- Seymour R.M. Important drug-drug interactions in the elderly / R.M. Seymour, P.A. Routledge // Drugs Aging. – 1998. – №12. – Р. 485-494.
- Sjoqvist F. Historical perspectives: drug interactions – it all began with cheese / F. Sjoqvist, Y. Bottiger // J Intern Med. – 2010. – №268(6). – Р. 512-515.
- Sjoqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances / F. Sjoqvist // Proceedings of the Royal Society of Medicine. – 1965. – №58. – Р. 967-978.
- Stanton L.A. Drug-related admissions to an Australian hospital / L.A. Stanton, G.M. Peterson, R.H. Rumble // J Clin Pharm Ther. – 1994. – №19. – Р. 341-347.
- von Euler M. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization / M. von Euler, E. Eliasson, G. Ohlen // Pharmacoepidemiol and Drug Saf. – 2006. – №15(3). – Р. 179-184.
Supplementary files
